West Pharmaceutical Services (NYSE:WST – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 6.350-6.650 for the period, compared to the consensus earnings per share estimate of 7.740. The company issued revenue guidance of $2.9 billion-$2.9 billion, compared to the consensus revenue estimate of $3.0 billion.
West Pharmaceutical Services Trading Up 2.8 %
NYSE:WST traded up $7.63 during trading hours on Friday, reaching $284.79. 1,190,411 shares of the company were exchanged, compared to its average volume of 563,505. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.61 and a quick ratio of 1.95. The firm has a market cap of $20.74 billion, a price-to-earnings ratio of 37.57, a PEG ratio of 5.75 and a beta of 1.00. West Pharmaceutical Services has a 52-week low of $265.00 and a 52-week high of $415.73. The stock has a 50 day simple moving average of $324.09 and a 200 day simple moving average of $355.75.
West Pharmaceutical Services (NYSE:WST – Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share for the quarter, missing analysts’ consensus estimates of $1.77 by ($0.25). The company had revenue of $702.10 million for the quarter, compared to analysts’ expectations of $729.36 million. West Pharmaceutical Services had a return on equity of 20.57% and a net margin of 19.42%. The business’s revenue for the quarter was down 6.9% on a year-over-year basis. During the same period in the prior year, the business earned $2.11 EPS. As a group, analysts predict that West Pharmaceutical Services will post 7.76 EPS for the current year.
Insider Activity
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Stories
- Five stocks we like better than West Pharmaceutical Services
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Where to Find Earnings Call Transcripts
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- What is an Earnings Surprise?
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.